BridgeMD
New treatment option for Glioma
Official title MRS of Glioma Genomics
ClinicalTrials.gov ID: NCT05700071
What this study is testing
- What it's testing
- In France, about 5000 new people with a primary malignant brain tumor are diagnosed each year. The most common primary tumors are gliomas, originating from glial cells (astrocytomas and oligodendrogliomas).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Affiliations to a social security scheme (as a beneficiary or a person entitled to benefits)
- Obtainig written, informed consent
- One of the following two situations
- Group 1 : Probable grade II/III/IV glioma, for which excision is scheduled.
- Group 2 : Histologically confirmed grade II or III glioma with known IDH1/IDH2 status, which has received no treatment other than surgery and is due...
You likely can't join if
- Containdications to MRI : Pacemaker or neural stimulators, intraocular or intracerebral metallic foreign bodies, cochlear implant, heart valve or...
- Pregnant or breastfeeding women
- Regulatory criteria : Pregnant women, women in labor, breastfeeding women ; Failure to sign the consent form or paticipant refusal ; Legal protection...
See the full eligibility criteria
- Affiliations to a social security scheme (as a beneficiary or a person entitled to benefits)
- Obtainig written, informed consent
- One of the following two situations
- Group 1 : Probable grade II/III/IV glioma, for which excision is scheduled.
- Group 2 : Histologically confirmed grade II or III glioma with known IDH1/IDH2 status, which has received no treatment other than surgery and is due to undergo therapy other than surgery.
- Presence of measurable tumor residue (\>2 cm in diameter on FLAIR imaging)
- Karnofsky Index \> 60
- Effective contraception throughout the study, supplemented by a negative pregnancy test for women of childbearing age.
- Containdications to MRI : Pacemaker or neural stimulators, intraocular or intracerebral metallic foreign bodies, cochlear implant, heart valve or metallic surgical arterial devices that are not MRI ompatible, metallic...
- Pregnant or breastfeeding women
- Regulatory criteria : Pregnant women, women in labor, breastfeeding women ; Failure to sign the consent form or paticipant refusal ; Legal protection measures (guardianship, curatorship, judicial protection)...
The study team makes the final eligibility decision.
Where it's taking place
- Paris, France
- Paris, Île-de-France Region, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, France; Paris, Île-de-France Region, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.